ChemoCentryx (CCXI) Stock Highlights

51.99 | +0%

2022-12-24 15:59:39

ChemoCentryx Inc is a biopharmaceutical company involved in the discovery, development, and commercialization of orally administered drugs to treat rare diseases, inflammatory disorders, autoimmune diseases, and cancer. The companys approach is to target the chemoattractant system, defined as a network of molecules (for example, chemokine ligands, their associated receptors, and chemoattractant receptors) known to cause inflammation. The targeted therapeutic areas are an antineutrophil cytoplasmic antibody, atypical hemolytic uremic syndrome, immunoglobulin A-mediated nephropathy (rare diseases category), pancreatic cancer, chronic kidney disease, psoriasis, rheumatoid arthritis, asthma, Crohns disease, inflammatory bowel disease, and others.

Statistics

Range Today

51.99 51.99

Volume Today 0

Range 1 Year

14.95 52

Volume 1 Year 408.59M

Range 3 Year

7.5 70.29

Volume 3 Year 1.26B

Range 10 Year

1.92 70.29

Volume 10 Year 1.75B

Highlights

Market Capitalization 3.64B (mid)

Floating Shares 58.98M

Current Price 51.99

Price To Earnings -55.59

Price To Revenue 92.66

Price To Book 10.04

Earnings Per Share -0.94

Payout Ratio 0%

Performance

Latest 0%

1 Month +0.41%

3 Months +117.26%

6 Months +146.28%

1 Year +49.83%

3 Years +563.14%

5 Years +637.45%

10 Years +373.5%

Benchmarks

Market Capitalization

52 / 368

Gross Profits

199 / 278

Total Revenue

137 / 300

Total Rank

303 / 368

Free Cashflow

226 / 352

Performance 5 years

13 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.